Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ventrus reports Iferanserin Phase 2b trial data
Iferanserin is a new chemical entity (NCE), that acts by targeting a specific serotonin receptor (5HT2A) for the topical treatment of hemorrhoids. The Phase 2b trial is a
Iferanserin is a new chemical entity (NCE), that acts by targeting a specific serotonin receptor (5HT2A) for the topical treatment of hemorrhoids. The Phase 2b trial is a
Priority Review for Cinryze was granted for all three requested indications, prevention, pre-procedure prevention, and acute treatment of attacks of Hereditary Angioedema (HAE). Priority Review will allow for
According to the company, the ability to fund both the Type 1 diabetes and GVHD human clinical trials are subject to the company raising additional capital in the
The drug candidate is currently in clinical phase II under the EU financed NEMO (Treatment of NEonatal seizures with Medication Off-patent project). Under the collaboration, O4CP will be
Krill oil is known to deliver high amounts of omega-3 without the risk of mercury and lead contamination as is the case with fish oil. The phospholipid structure
The Navy Medicine Research contract is a five-year, indefinite delivery, indefinite quantity, multiple-award contract with a total potential value of $497m to all awardees if all options are
Under the collaboration, the Max Planck Institute will conduct a series of influenza virus growth studies to determine the advantages of Biovest’s proprietary Hollow Fiber Bioreactor Systems for
Carbamazepine Extended-Release Capsules are therapeutically equivalent and substitutable for the brand Carbatrol. Carbatrol is used to treat certain types of seizures (partial, tonic-clonic, mixed) and certain types of
PTM is an injectable suspension of microencapsulated insulin-producing, pancreatic islet cells which are harvested from designated pathogen free pigs. As per the deal, PCT will perform microencapsulation for
The folder will produce patient-information leaflets for the healthcare market. The MV-11 Outsert System folds outserts as small as 1-1/8" x 1-1/8", flatter, 15% thinner, and with up